Advertisement
Grab your lab coat. Let's get started
Welcome!
Welcome!
Create an account below to get 6 C&EN articles per month, receive newsletters and more - all free.
It seems this is your first time logging in online. Please enter the following information to continue.
As an ACS member you automatically get access to this site. All we need is few more details to create your reading experience.
Not you? Sign in with a different account.
Not you? Sign in with a different account.
ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Business
Wyeth in pact with Indian CRO
January 23, 2006
| A version of this story appeared in
Volume 84, Issue 4
Wyeth has signed a multiyear research pact with the Indian contract research organization (CRO) GVK Biosciences. Under the deal, GVK will establish a dedicated discovery chemistry research site and by early 2007 will have hired 150 synthetic chemists to work exclusively for Wyeth. The decision to partner with the Indian CRO was based on the "ever-growing chemistry skills base in Asia," India's recent adoption of international patent laws, and the quality of science at GVK, says Frank Walsh, executive vice president and head of discovery research at Wyeth.
You might also like...
The power is now in your (nitrile gloved) hands
Sign up for a free account to get more articles. Or choose the ACS option that’s right for you.
Already have an ACS ID? Log in
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter